Reference
Szafron V, et al. A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY. Annals of Allergy, Asthma and Immunology 125 (Suppl.): S106-S107, No. 5, Nov 2020 [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab/anakinra/dexamethasone. Reactions Weekly 1829, 19 (2020). https://doi.org/10.1007/s40278-020-85609-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85609-7